Vascular Biogenics Ltd.

NasdaqCM:VBLT Stok Raporu

Piyasa değeri: US$12.1m

Vascular Biogenics Gelecekteki Büyüme

Future kriter kontrolleri 0/6

We currently don't have sufficient analyst coverage to forecast growth and revenue for Vascular Biogenics.

Anahtar bilgiler

n/a

Kazanç büyüme oranı

n/a

EPS büyüme oranı

Biotechs kazanç büyümesi27.1%
Gelir büyüme oranın/a
Gelecekteki özkaynak getirisin/a
Analist kapsamı

None

Son güncellemen/a

Gelecekteki son büyüme güncellemeleri

Recent updates

VBL Therapeutics receives non-compliance letter from Nasdaq

Sep 01

VBL Therapeutics GAAP EPS of -$0.12

Aug 15

VBL Therapeutics' late-stage trial for ovarian cancer treatment does not meet main goals

Jul 19

Here's Why We're Watching Vascular Biogenics' (NASDAQ:VBLT) Cash Burn Situation

May 18
Here's Why We're Watching Vascular Biogenics' (NASDAQ:VBLT) Cash Burn Situation

Vascular Biogenics Trial Nears Full Enrollment, Price Could Jump

Sep 03

How Much Are Vascular Biogenics Ltd. (NASDAQ:VBLT) Insiders Spending On Buying Shares?

Mar 17
How Much Are Vascular Biogenics Ltd. (NASDAQ:VBLT) Insiders Spending On Buying Shares?

How Much Of Vascular Biogenics Ltd. (NASDAQ:VBLT) Do Insiders Own?

Jan 28
How Much Of Vascular Biogenics Ltd. (NASDAQ:VBLT) Do Insiders Own?

VBL Therapeutics expands the ovarian cancer trial in Europe

Dec 29

Is Vascular Biogenics (NASDAQ:VBLT) In A Good Position To Deliver On Growth Plans?

Dec 24
Is Vascular Biogenics (NASDAQ:VBLT) In A Good Position To Deliver On Growth Plans?

Vascular Biogenics Ltd. (NASDAQ:VBLT) Just Reported And Analysts Have Been Cutting Their Estimates

Nov 19
Vascular Biogenics Ltd. (NASDAQ:VBLT) Just Reported And Analysts Have Been Cutting Their Estimates

VBL Therapeutics EPS beats by $0.01, misses on revenue

Nov 16

Bu bölümde, yatırımcıların şirketin kâr elde etme kabiliyetini anlamalarına yardımcı olmak için genellikle profesyonel analistlerin fikir birliği tahminlerine dayanan gelir ve kazanç büyüme tahminlerini sunuyoruz. Ancak Vascular Biogenics yeterli geçmiş veri sağlamadığından ve analist tahmini olmadığından, gelecekteki kazançları geçmiş verileri ekstrapole ederek veya analist tahminlerini kullanarak güvenilir bir şekilde hesaplanamaz.

SimplyWall St tarafından kapsanan şirketlerin %97'si geçmiş finansal verilere sahip olduğu için bu oldukça nadir bir durumdur.

Kazanç ve Gelir Büyüme Tahminleri

NasdaqCM:VBLT - Analistlerin gelecek tahminleri ve geçmiş finansal verileri (USD Millions )
TarihGelirKazançlarSerbest Nakit AkışıFaaliyetlerden NakitAvg. Analist Sayısı
6/30/20230-16-18-18N/A
3/31/20231-25-25-25N/A
12/31/20221-32-32-32N/A
9/30/20221-38-33-32N/A
6/30/20221-35-33-32N/A
3/31/20221-34-29-27N/A
12/31/20211-30-26-25N/A
9/30/20211-28-26-25N/A
6/30/20211-27-23-22N/A
3/31/20211-25-24-23N/A
12/31/20201-24-23-23N/A
9/30/20201-23-21-21N/A
6/30/20201-22-21-21N/A
3/31/20201-21-16-16N/A
12/31/20191-19-13-13N/A
9/30/20191-18-12-12N/A
6/30/20191-18-13-13N/A
3/31/20191-17-16-15N/A
12/31/20181-20-18-16N/A
9/30/201814-10-7-2N/A
6/30/201814-11-8-1N/A
3/31/201814-12-10-2N/A
12/31/201714-10-10-4N/A
9/30/2017N/A-21-22-18N/A
6/30/2017N/A-18-18-17N/A
3/31/2017N/A-16N/A-15N/A
12/31/2016N/A-16N/A-13N/A
9/30/2016N/A-14N/A-14N/A
6/30/2016N/A-17N/A-15N/A
3/31/2016N/A-17N/A-15N/A
12/31/2015N/A-15N/A-13N/A
9/30/2015N/A-17N/A-12N/A
6/30/2015N/A-15N/A-13N/A
3/31/2015N/A-15N/A-13N/A
12/31/2014N/A-17N/A-14N/A
9/30/2014N/A-18N/A-15N/A
12/31/2013N/A-17N/A-13N/A

Analist Gelecek Büyüme Tahminleri

Kazançlar ve Tasarruf Oranları: Insufficient data to determine if VBLT's forecast earnings growth is above the savings rate (2.2%).

Kazançlar ve Piyasa: Insufficient data to determine if VBLT's earnings are forecast to grow faster than the US market

Yüksek Büyüme Kazançları: Insufficient data to determine if VBLT's earnings are expected to grow significantly over the next 3 years.

Gelir ve Pazar: Insufficient data to determine if VBLT's revenue is forecast to grow faster than the US market.

Yüksek Büyüme Geliri: Insufficient data to determine if VBLT's revenue is forecast to grow faster than 20% per year.


Hisse Başına Kazanç Büyüme Tahminleri


Gelecekteki Özkaynak Getirisi

Gelecekteki ROE: Insufficient data to determine if VBLT's Return on Equity is forecast to be high in 3 years time


Büyüyen şirketleri keşfedin